About

Publications While At HealthPartners

selected publications

Journal Article

Phase 2 trial of nivolumab and ramucirumab for relapsed mesothelioma: HCRN-LUN15-299. 

JTO Clin Res Rep. 2023

Contact

full name

T. Tanvetyanon

Quick Info

 

Collaboration

Co-author network

Map of science